Vaccine against herpes zoster

The herpes zoster vaccine is made using high doses of live attenuated varicella/zoster virus. The vaccine is well tolerated and has few adverse effects: the most common one is pain at the injection site. Complications can occur mainly in persons who had prior zoster keratitis or uveitis. The vaccine...

Descripción completa

Detalles Bibliográficos
Autor principal: Pasternak, Jacyr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2013
Materias:
Medical Developments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872985/
https://www.ncbi.nlm.nih.gov/pubmed/23579760
http://dx.doi.org/10.1590/S1679-45082013000100026
_version_ 1782432814796374016
author Pasternak, Jacyr
author_facet Pasternak, Jacyr
author_sort Pasternak, Jacyr
collection PubMed
description The herpes zoster vaccine is made using high doses of live attenuated varicella/zoster virus. The vaccine is well tolerated and has few adverse effects: the most common one is pain at the injection site. Complications can occur mainly in persons who had prior zoster keratitis or uveitis. The vaccine can prevent this disease with low mortality but high morbidity.
format Online
Article
Text
id pubmed-4872985
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Instituto Israelita de Ensino e Pesquisa Albert Einstein
record_format MEDLINE/PubMed
spelling pubmed-48729852016-08-10 Vaccine against herpes zoster Pasternak, Jacyr Einstein (Sao Paulo) Medical Developments The herpes zoster vaccine is made using high doses of live attenuated varicella/zoster virus. The vaccine is well tolerated and has few adverse effects: the most common one is pain at the injection site. Complications can occur mainly in persons who had prior zoster keratitis or uveitis. The vaccine can prevent this disease with low mortality but high morbidity. Instituto Israelita de Ensino e Pesquisa Albert Einstein 2013 /pmc/articles/PMC4872985/ /pubmed/23579760 http://dx.doi.org/10.1590/S1679-45082013000100026 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Medical Developments
Pasternak, Jacyr
Vaccine against herpes zoster
title Vaccine against herpes zoster
title_full Vaccine against herpes zoster
title_fullStr Vaccine against herpes zoster
title_full_unstemmed Vaccine against herpes zoster
title_short Vaccine against herpes zoster
title_sort vaccine against herpes zoster
topic Medical Developments
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872985/
https://www.ncbi.nlm.nih.gov/pubmed/23579760
http://dx.doi.org/10.1590/S1679-45082013000100026
work_keys_str_mv AT pasternakjacyr vaccineagainstherpeszoster

Ejemplares similares